CERUS Aktie: Aktienkurs, Chart & News| US

Diesen Artikel teilen. Cerus Corporation is a biomedical products company focused in the field of blood safety.

04.20.2021
  1. Cerus Corporation - Investor News & Events - Events & Webcasts, cerus aktie
  2. Cerus Corporation Announces Expansion of BARDA. - Aktien
  3. Cerus - Crunchbase Company Profile & Funding
  4. Working at Cerus Corporation | Glassdoor
  5. Cerus Corp Stock Quote: CERS Stock News, Quotes, Analysis
  6. Cerus Corporation Announces Preliminary Fourth Quarter and
  7. Cerus Corporation - Financial & Filings - SEC Filings
  8. Cerus Corporation (CERS) Stock Price Today, Quote & News
  9. Cerus Corporation (CERS) Q3 Earnings Call Transcript
  10. Cerus Corporation (CERS) Latest Stock News & Headlines
  11. Cerus (CERS) Stock Price, Quote & News | Stock Analysis

Cerus Corporation - Investor News & Events - Events & Webcasts, cerus aktie

CERUS ENERGY GROUP Times and Sales - hier finden Sie eine Übersicht über die Käufe und Verkäufe (Umsätze) mit Uhrzeit und Volumen der CERUS ENERGY GROUP Aktie an allen Börsenplätzen.CERUS| USmit aktuellem Aktienkurs, Charts, News und Analysen.
Headquartered in Concord, California, the company develops and supplies vital technologies and pathogen-protected blood components to blood centers, hospitals, and ultimately patients who rely on safe.The Company is engaged in developing and commercializing the INTERCEPT Blood System for blood safety.
0 Kommentare.

Cerus Corporation Announces Expansion of BARDA. - Aktien

A high-level overview of Cerus Corporation (CERS) stock.
In the same quarter last year, Cerus posted EPS of $0.
: CERUS CORP: INTERCEPT Plasma inscrit au Journal Officiel.
26, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Sector.
Its INTERCEPT Blood System, a proprietary technology for controlling biological replication is designed to reduce blood-borne pathogens in donated blood components intended for transfusion.
CERUS CORPORATION Stock technical analysis with dynamic chart and Delayed Quote | Nasdaq: CERS | Nasdaq. Cerus aktie

Cerus - Crunchbase Company Profile & Funding

0 Kommentare. Aktien » Nachrichten » CERUS AKTIE » Cerus Corporation Announces Presentation of Study Results with INTERCEPT-treated COVID-19 Convalescent Plasma at the American Society of Hematology Annual. Cerus Corporation is dedicated solely to safeguarding the world’s blood supply and aims to become the preeminent global blood products company. Food and Drug Administration (FDA) for the developme. · View today's stock price, news and analysis for Cerus Corp. · CERUS issued a press release today announcing our financial results for the third quarter ended Septem, and describing the company's recent business highlights. Cerus aktie

Working at Cerus Corporation | Glassdoor

· Cerus Corporation (Nasdaq:CERS) announced today it was awarded a five-year contract with the U. Cerus Corporation Aktie. 0 Kommentare. Cerus Corporation Aktie. Headquartered in Concord, California, the company develops and supplies vital technologies and pathogen-protected blood components to blood centers, hospitals, and ultimately patients who rely on safe. Headquartered in Concord, California, the company develops and supplies vital technologies and pathogen-protected blood components to blood centers, hospitals, and ultimately patients who rely on safe. Cerus aktie

Cerus Corp Stock Quote: CERS Stock News, Quotes, Analysis

  • (CERS).
  • KG assumes no warranty for the accuracy, completeness or currentness of the content provided, particularly for price, market, exchange or other financial information.
  • (PSTG) stock quote, history, news and other vital information to help you with your stock trading and investing.
  • Cerus Corporation’s share price is determined by its bid-ask spread, which is the difference between the price that buyers are willing to pay and the price that sellers are willing to accept.
  • Cerus Corporation Aktie jetzt über den Testsieger (Finanztest 11/) handeln, ab 0 € auf.
  • Wertpapier.

Cerus Corporation Announces Preliminary Fourth Quarter and

Array Array Array Cerus aktie

CERUS Aktie Orderbuch Xetra - Bid-Ask Volumen mit aktuellen Kursen - Times & Sales zuUSRealtimekurse.
Dies beinhaltet die Agentur-Feeds auf, aber auch Cerus News auf einer Vielzahl externer Seiten.

Cerus Corporation - Financial & Filings - SEC Filings

Cerus Corporation is dedicated solely to safeguarding the world’s blood supply and aims to become the preeminent global blood products company. 09 on sales of $32. Wertpapier. Cerus Corporation (NASDAQ:CERS) is not the least popular stock in this group but hedge fund interest is still below average. 12 on sales of. Cerus Corporation is a biomedical products company. Cerus aktie

Cerus Corporation (CERS) Stock Price Today, Quote & News

Cerus Corporation Aktie.
· Cerus Corporation, a biomedical products company, focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety.
(1) Restriction of liability.
The P/E ratio of Cerus is -16.
Earnings And Revenue Cerus's per-share loss will be near $0.
| 905249 | CERS | US. Cerus aktie

Cerus Corporation (CERS) Q3 Earnings Call Transcript

Array Array Array Array Cerus aktie

Diesen Artikel teilen.
CERUS CORPORATION: publication des résultats trimestriels: : CERUS CORPORATION: publication des résultats trimestriels: : CERUS CORPORATION: publication des résultats trimestriels: : CERUS CORP: Cerus annonce avoir passé un accord portant sur la fourniture du sy.

Cerus Corporation (CERS) Latest Stock News & Headlines

Cerus Corporation Aktie jetzt über den Testsieger (Finanztest 11/) handeln, ab 0 € auf.This is a slightly negative signal and we'd rather spend our time.
42 million, according to Wall Street analysts.Earnings for Cerus are expected to grow in the coming year, from ($0.
The Market.Cerus Corporation (CERS) is up over 13% at $7.

Cerus (CERS) Stock Price, Quote & News | Stock Analysis

Array Array Array Array Cerus aktie

Wertpapier.
Based in Concord, California, our employees are dedicated to deploying and supplying vital technologies and pathogen-protected blood.